Please provide your email address to receive an email when new articles are posted on . There is no neonatal benefit or harm when using tocolytic drugs for threatened premature birth after 30 weeks’ ...

A decline in the levels of the coenzyme nicotinamide adenine dinucleotide (NAD+) in the placenta may help trigger labor by allowing prostaglandins to accumulate, raising the possibility of new ...

Tocolytics are short-term treatments used to allow time for interventions that can improve the outcomes of preterm labor and delivery for both mother and child. Since no single tocolytic drug is ...

New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model.

Scientists have found that targeting a particular group of proteins in the uterus muscle (myometrium) can suppress human ...

A research team at the Medical University of South Carolina reports in Cells that the complement system, part of the body's natural immune defenses, is a key driver of inflammatory responses that ...

In honor of Women’s Health Month, reproductive health researcher and Assistant Professor Scott Barnett from the Department of Biochemistry & Molecular Biology shares the sobering reality of the rising ...

Few women of childbearing age consume adequate amounts of omega-3 fatty acids. Caroline Purser/The Image Bank via Getty Images Most prenatal supplements lack the amount of omega-3 fatty acids that ...

WASHINGTON -- The high rate of premature births in the United States constitutes a public health concern that costs society at least $26 billion a year, according to a new report from the Institute of ...